SPY
759.12
+0.26%
QQQ
689.27
+0.16%
BTC/USD
69,194.08
−3.05%
DIA
523.49
+0.20%
GLD
356.93
+0.57%
TLT
79.49
−0.29%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Penny Stocks
Vivani Medical Advances Long-Acting Semaglutide Implant Toward Phase 2 Trial in 2027
Traws Pharma Advances Oral COVID-19, Monthly Flu Antiviral Toward Next Milestones
Datavault AI Stock Rallies After Board Fires CEO, Several Execs Replaced
Traws Pharma Advances Oral COVID-19, Monthly Flu Antiviral Toward Next Milestones
Datavault AI Stock Rallies After Board Fires CEO, Several Execs Replaced
Nexera Technologies (NEXR) Stock Drops 29%: What's Happening?
Solowin Holdings Stock Craters as Steep Reverse Split Looms
Nexera Technologies (NEXR) Stock Drops 29%: What's Happening?
Solowin Holdings Stock Craters as Steep Reverse Split Looms
Datavault AI Stock Crashes — Financials Cannot Be Trusted: What You Need to Know
22nd Century Group Stock Climbs 21% After-Hours: What's Going On?
Read More...
Penny Stocks Recent News
Lexin Faces Potential Nasdaq Delisting Amid Mounting Pressure For China Fintechs
The online loan facilitator faces a potential delisting after its American depositary shares traded below $1 for 30 consecutive business days image credit: Bamboo Works Key Takeaways: Lexin’s American
Why Is Dermata Therapeutics Stock Gaining Thursday?
Dermata Therapeutics (DRMA) jumps 34% after positive clinical results for its weekly Bioneedle Tome Foundational Treatment.
WF Holding Stock Plunges After $18 Million Offering With Heavy Dilution Risk
WF Holding shares plunged and trading halted after an $18M offering with warrants that could add up to 120M shares, risking severe dilution.
Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech
Profusa received ISO 13485 certification from GMED, advancing its Lumee Oxygen Platform toward CE marking in the European Union.
What's Going On With Cheetah Net Stock Thursday?
Cheetah Net shares remain volatile after its JoyPak deal, with CTNT stock climbing 72% Thursday amid heavy trading interest.
Reitar Logtech (RITR) Shares Tumble 69% After Hours: Here's Why
Reitar Logtech shares fell 69% after hours after Nasdaq issued a delisting determination.
Delixy Stock Explodes Higher on Potential 48% Kazakhstan Oil Stake
Delixy Holdings Stock surges 418% after a non-binding LOI for a potential 48% stake in a Kazakhstan oil and gas project.
SOBR Safe (SOBR) Shares Tumble 36% After Hours: Here's Why
SOBR Safe shares tumble after hours after Nasdaq announces delisting over listing compliance issues.
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations
VolitionRx reports 112% revenue growth in H1 2026 while advancing its Nu.Q diagnostic platforms across sepsis and oncology markets.
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
Sunshine Biopharma outlines K1.1 mRNA pipeline updates, advancing dual oncology therapy to target cold tumors in liver and lung cancer.
What's Going On With SU Group Stock Monday?
SU Group (SUGP) unit wins exclusive Macao rights for AI Inspec Spider system. Pre-market stock dips 6.8% to $1.49.
Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal
Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.
Onfolio Holdings (ONFO) Stock Drops 27% After Hours: Here’s What’s Going On?
Onfolio stock plunges 26% after hours following second-quarter results.
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Loading...
Loading watchlists...